WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$150,565,456
+12.5%
946,893
+0.1%
0.50%
+16.6%
Q2 2023$133,802,629
-12.8%
945,869
+3.8%
0.43%
-19.8%
Q1 2023$153,437,916
+34.5%
911,368
+35.3%
0.54%
+22.7%
Q4 2022$114,042,475
+11.3%
673,572
+23.1%
0.44%
+7.7%
Q3 2022$102,421,000
-14.0%
547,384
-25.3%
0.40%
-8.2%
Q2 2022$119,053,000
+57.5%
733,086
-46.2%
0.44%
+68.3%
Q3 2018$75,598,000
-11.0%
1,363,109
-24.5%
0.26%
-17.1%
Q2 2018$84,969,000
+30.0%
1,806,304
-0.0%
0.32%
+26.4%
Q1 2018$65,367,000
-0.0%
1,806,703
+0.2%
0.25%
-1.6%
Q4 2017$65,397,000
+61.0%
1,802,569
+70.1%
0.25%
+75.2%
Q3 2017$40,617,000
-7.4%
1,059,935
+0.1%
0.14%
-9.4%
Q2 2017$43,884,000
+76.4%
1,058,976
+49.8%
0.16%
+70.2%
Q1 2017$24,884,000
+19.3%
706,931
+4.5%
0.09%
+13.3%
Q4 2016$20,857,000
+3.0%
676,733
+0.9%
0.08%
+7.8%
Q3 2016$20,255,000
-7.1%
670,913
-15.8%
0.08%
-10.5%
Q2 2016$21,804,000
+184.6%
796,944
+179.0%
0.09%
+186.7%
Q1 2016$7,661,000
+68.3%
285,648
+77.5%
0.03%
+66.7%
Q4 2015$4,552,000
-1.5%
160,893
-3.1%
0.02%
+100.0%
Q3 2015$4,623,000166,0050.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders